• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家乳腺癌手术辅助治疗项目(协议号4)的病理研究结果。VI. 五年治疗失败的判别因素。

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.

作者信息

Fisher E R, Redmond C, Fisher B

出版信息

Cancer. 1980 Aug 15;46(4 Suppl):908-18. doi: 10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5.

DOI:10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5
PMID:7397667
Abstract

Thirty-six pathologic and six clinical characteristics observed in 581 patients enrolled in protocol no. 4 of the National Surgical Adjuvant Breast Project were treated by radical mastectomy and were correlated with five-year treatment failure. The cases were initially stratified according to pathologic nodal status, the most important discriminant in breast cancer. The presence of tumor necrosis, poor tumor differentiation (histologic grade 3) and a tumor size > 4 cm were found by multivariate analyses to influence treatment failure in patients without nodal metastases. Prognosis was usually worse in individuals whose tumors exhibited all of these features than in those in whom only one or two could be detected. Although the sample size was small, life-table analysis also disclosed a highly significant relationship between treatment failure and a germinal center predominance pattern in regional nodes in this subset of patients. Except for this latter, these same discriminants were similarly noted to affect treatment failure in those patients with four or more nodal metastases but not those with only 1--3 positive nodes. A possible explanation for this inconsistency among nodal categories is discussed. Nevertheless, it is concluded that these rather easily measured pathologic parameters represent important discriminants for the prognosis and the design of treatment schemes and subsequent protocols for patients with breast cancer, particularly those without regional nodal metastasis. The findings amplify the importance of intrinsic tumor characteristics as well as possibly host factors in accounting for the clinical behavior of patients with breast cancer.

摘要

对参与国家乳腺癌辅助手术项目4号方案的581例患者观察到的36项病理特征和6项临床特征进行了研究,这些患者均接受了根治性乳房切除术,并与五年治疗失败情况进行了关联分析。病例最初根据病理淋巴结状态进行分层,这是乳腺癌最重要的判别因素。多变量分析发现,肿瘤坏死、肿瘤分化差(组织学3级)以及肿瘤大小>4 cm会影响无淋巴结转移患者的治疗失败情况。肿瘤表现出所有这些特征的个体的预后通常比仅能检测到一两项这些特征的个体更差。尽管样本量较小,但生存表分析也揭示了在这部分患者中,治疗失败与区域淋巴结生发中心优势模式之间存在高度显著的关系。除了后者,同样的判别因素在有四个或更多淋巴结转移的患者中同样被发现会影响治疗失败情况,但在仅有1 - 3个阳性淋巴结的患者中则不然。本文讨论了淋巴结类别之间这种不一致的可能解释。然而,得出的结论是,这些相当容易测量的病理参数是乳腺癌患者预后以及治疗方案和后续方案设计的重要判别因素,尤其是对于那些没有区域淋巴结转移的患者。这些发现进一步强调了肿瘤内在特征以及可能的宿主因素在解释乳腺癌患者临床行为方面的重要性。

相似文献

1
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no. 4). VI. Discriminants for five-year treatment failure.国家乳腺癌手术辅助治疗项目(协议号4)的病理研究结果。VI. 五年治疗失败的判别因素。
Cancer. 1980 Aug 15;46(4 Suppl):908-18. doi: 10.1002/1097-0142(19800815)46:4+<908::aid-cncr2820461310>3.0.co;2-5.
2
Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure.国家乳腺癌手术辅助项目(方案编号4)的病理研究结果。X. 十年治疗失败的判别因素。
Cancer. 1984 Feb 1;53(3 Suppl):712-23. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i.
3
Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). II. The significance of regional node histology other than sinus histiocytosis in invasive mammary cancer.国家乳腺手术辅助治疗项目(协议编号4)的病理研究结果。II. 浸润性乳腺癌中除窦组织细胞增生症外区域淋巴结组织学的意义。
Am J Clin Pathol. 1976 Jan;65(1):21-30. doi: 10.1093/ajcp/65.1.21.
4
Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4). Discriminants for 15-year survival. National Surgical Adjuvant Breast and Bowel Project Investigators.国家乳腺外科辅助治疗项目(协议4)的病理研究结果。15年生存率的判别因素。国家乳腺与肠道外科辅助治疗项目研究人员。
Cancer. 1993 Mar 15;71(6 Suppl):2141-50. doi: 10.1002/1097-0142(19930315)71:6+<2141::aid-cncr2820711603>3.0.co;2-f.
5
Prognostic and therapeutic significance of pathological features of breast cancer.
NCI Monogr. 1986(1):29-34.
6
Pathologic findings from the national surgical adjuvant breast project. (Protocol no. 4). III. The significance of extranodal extension of axillary metastases.
Am J Clin Pathol. 1976 Apr;65(4):439-44. doi: 10.1093/ajcp/65.4.439.
7
Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.术前化疗的病理生物学:来自国家外科辅助乳腺和肠道项目(NSABP)B-18方案的研究结果。
Cancer. 2002 Aug 15;95(4):681-95. doi: 10.1002/cncr.10741.
8
Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06.浸润性乳腺癌的15年预后判别因素:国家外科辅助乳腺和肠道项目协议-06
Cancer. 2001 Apr 15;91(8 Suppl):1679-87.
9
The impact of the size of nodal metastases on recurrence risk in breast cancer patients with 1-3 positive axillary nodes after mastectomy.乳腺癌改良根治术后 1-3 个腋窝淋巴结阳性患者中,淋巴结转移灶大小对复发风险的影响。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):609-14. doi: 10.1016/j.ijrobp.2012.05.050. Epub 2012 Aug 3.
10
Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.T1至T3期肿瘤且经细胞学证实有腋窝转移性淋巴结的乳腺癌患者在接受初次化疗后腋窝完全降期的发生率及预后意义。
J Clin Oncol. 2002 Mar 1;20(5):1304-10. doi: 10.1200/JCO.2002.20.5.1304.

引用本文的文献

1
Invasive micropapillary breast carcinoma: A retrospective study on the clinical imaging features and pathologic findings.浸润性微乳头状乳腺癌:临床影像特征与病理结果的回顾性研究
Front Surg. 2022 Sep 23;9:1011773. doi: 10.3389/fsurg.2022.1011773. eCollection 2022.
2
High-dose chemotherapy followed by autologous stem cell transplantation as a first-line therapy for high-risk primary breast cancer: a meta-analysis.大剂量化疗后自体造血干细胞移植作为高危原发性乳腺癌的一线治疗:一项荟萃分析。
PLoS One. 2012;7(3):e33388. doi: 10.1371/journal.pone.0033388. Epub 2012 Mar 12.
3
The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.
基质细胞刺激在恶化一部分乳腺癌患者预后方面的潜在作用。
Clin Exp Metastasis. 1993 Jul;11(4):295-305. doi: 10.1007/BF00058049.
4
Correlation of primary breast cancer histopathology and estrogen receptor content.
Breast Cancer Res Treat. 1981;1(1):37-41. doi: 10.1007/BF01807890.
5
Scar cancers: pathologic findings from the National Surgical Adjuvant Breast Project (protocol no. 4) - IX.
Breast Cancer Res Treat. 1983;3(1):39-59. doi: 10.1007/BF01806233.
6
Breast cancer in women under 30 years of age.30岁以下女性的乳腺癌
Breast Cancer Res Treat. 1985;6(2):137-44. doi: 10.1007/BF02235745.
7
Tissue mast cells in breast cancer.
Breast Cancer Res Treat. 1985;5(3):285-91. doi: 10.1007/BF01806023.
8
Patterns of metastasis and natural courses of breast carcinoma.乳腺癌的转移模式与自然病程。
Cancer Metastasis Rev. 1985;4(2):153-72. doi: 10.1007/BF00050693.
9
Prognosis in node-negative breast cancer.淋巴结阴性乳腺癌的预后
Breast Cancer Res Treat. 1986;8(3):189-96. doi: 10.1007/BF01807331.
10
Breast cancer. Advances in management.乳腺癌。治疗进展。
Drugs. 1988 May;35(5):584-95. doi: 10.2165/00003495-198835050-00006.